Fallout in China from Nu Skin affair depresses Usana's Q2 results
Usana Health Sciences reported flat net sales in the second quarter of its 2014 fiscal year. Issues in China caused the company to miss analysts’ estimates for sales and earnings, and the company’s share price took a plunge as a result.